MedTrace Logo

Stem Cell Therapy in Traumatic Brain Injury

NCT02028104 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2018-10-25

No results posted yet for this study

Summary

The purpose of this study was to study the effect of stem cell therapy on common symptoms in patients with Traumatic Brain Injury

Conditions

Interventions

BIOLOGICAL

Autologous bone marrow mononuclear cell transplantation

bone marrow derived mononuclear cells are administered intrathecally in traumatic brain injury patients

Sponsors & Collaborators

  • Neurogen Brain and Spine Institute

    lead OTHER

Principal Investigators

  • Alok K Sharma, M.S., M.Ch · Neurogen Brain and Spine Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Months
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2016-04-30
Completion
2016-09-30

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02028104 on ClinicalTrials.gov